Day CP - Search Results

1

Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors.

Schwantes-An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Muellhaupt B, Stickel F, Soyka M, Goldman D, Liang T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Botwin G, Haber PS, Seitz HK, Day CP, Foroud TM, Daly AK, Cordell HJ, Whitfield JB, Morgan TR, Seth D; GenomALC Consortium. Schwantes-An TH, et al. Among authors: day cp. Hepatology. 2021 May;73(5):1920-1931. doi: 10.1002/hep.31535. Hepatology. 2021. PMID: 32853455 Free article.

2

No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis.

Bashir R, Day CP, James OF, Ogilvie DJ, Sykes B, Bassendine MF. Bashir R, et al. Among authors: day cp. J Hepatol. 1992 Nov;16(3):316-9. doi: 10.1016/s0168-8278(05)80662-2. J Hepatol. 1992. PMID: 1362577

3

Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage.

Day CP, Bashir R, James OF, Bassendine MF, Crabb DW, Thomasson HR, Li TK, Edenberg HJ. Day CP, et al. Hepatology. 1991 Nov;14(5):798-801. doi: 10.1002/hep.1840140509. Hepatology. 1991. PMID: 1937384

4

Digoxin-like factors in liver disease.

Day CP, James OF. Day CP, et al. J Hepatol. 1989 Sep;9(2):281-4. doi: 10.1016/0168-8278(89)90064-0. J Hepatol. 1989. PMID: 2681397 Review. No abstract available.

5

The natural history of nonalcoholic fatty liver: a follow-up study.

Teli MR, James OF, Burt AD, Bennett MK, Day CP. Teli MR, et al. Among authors: day cp. Hepatology. 1995 Dec;22(6):1714-9. Hepatology. 1995. PMID: 7489979

6

The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beings.

Day CP, James OF, Brown AS, Bennett MK, Fleming IN, Yeaman SJ. Day CP, et al. Hepatology. 1993 Oct;18(4):832-8. doi: 10.1002/hep.1840180413. Hepatology. 1993. PMID: 8406356

7

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.

Reeves HL, Burt AD, Wood S, Day CP. Reeves HL, et al. Among authors: day cp. J Hepatol. 1996 Nov;25(5):677-83. doi: 10.1016/s0168-8278(96)80238-8. J Hepatol. 1996. PMID: 8938545 Clinical Trial.

8

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

Grove J, Daly AK, Bassendine MF, Day CP. Grove J, et al. Among authors: day cp. Hepatology. 1997 Jul;26(1):143-6. doi: 10.1002/hep.510260119. Hepatology. 1997. PMID: 9214463

9

Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.

Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Day CP, et al. Diabetologia. 1998 Apr;41(4):430-4. doi: 10.1007/s001250050926. Diabetologia. 1998. PMID: 9562347

10

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Smith BC, et al. Among authors: day cp. Hepatology. 1998 Jun;27(6):1695-9. doi: 10.1002/hep.510270631. Hepatology. 1998. PMID: 9620344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page